Non-invasive Measurements of Intestinal Failure-Associated Steatosis among adult patients.

Non-invasive Measurements of Intestinal Failure-Associated Steatosis among adult patients. - Intestinal failure-associated steatosis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON45917

Enrollment

Registered

2018-10-01

Start date

2019-02-25

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

leverproblematiek bij darmfalen (IFALD) fatty liver Intestinal failure-associated liver disease (IFALD)

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * Use of parenteral nutrition and/ or intravenous fluids > 3 months, at least 2 times per week ten gevolge van darmfalen

Exclusion criteria

Exclusion criteria: * BMI > 30 kg/m2 * Metastasized malignancy, or malignancy currently under treatment * Pregnancy or breastfeeding * Severe claustrophobia, presence of metallic implants, or not able to undergo MR measurements of the liver due to other reasons * Blood transfusion or transfusion with a ferric compound within one month of study * Subject have had a liver transplantation in the past * Subject has a history of non-medical substance drug abuse within the 6 months prior to study start * Known obstructive cholestasis at time of measurements (yes/no) * Major / systemic infection at time of measurement

Design outcomes

Primary

Measure	Time frame
Steatosis severity (%)	—

Secondary

Measure	Time frame
Presence or absence of steatosis (	—

Countries

Netherlands

Outcome results